Self-Injections Market | Global Industry Analysis, Size, Share, Growth, Trends and Forecast Period 2017-2024

The latest ready report on “Global Self-Injections Market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024”, also the Global Self-Injections Market, By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel, Geography (North America, Europe, APAC, MEA, South America) – Trends and Forecast to 2024

This report consists of below pages:

• No of pages: 350
• No of Figures: 60
• No of Tables: 220

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-self-injections-market

The global self-injections market is expected to grow exponentially in the forecast period. The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases, chronic diseases include heart disease, diabetes, stroke, and chronic respiratory problems.

Competitive Landscape:

The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major Companies operating in this market are:

• Abbvie, Inc.
• Antares Pharma
• 3M
• Becton Dickinson & Company
• Baxter International Inc.
• Penjet Corporation
• PharmaJet
• GerresheimerAG
• Pfizer Inc.
• Terumo Corporation
• Mylan N.V.
• SHL Group
• Bespak
• Janssen Biotech Inc.
• Insulet Corporation
• Unilife Corporation
• West Pharmaceutical Services, Inc.
• Ypsomed
• Eli lilly and Company
• Haselmeier AG
• Alkermes
• AptarPharma
• Credence MedSystems, Inc.
• SchottAG
• Owen Mumford Ltd.
• Glide Technologies

View Full Report @ http://databridgemarketresearch.com/reports/global-self-injections-market-/

Report Segmentation:

The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography.

On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.

The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.

The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into automated and manual. The design segment is further categorized into standardized and customized. The usability segment is further categorized into reusable and disposable.

The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized.

The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The conventional drug delivery segment is categorized into solutions, reconstituted/lyophilized formulations, suspensions and emulsions. The novel drug delivery formulations market is segmented into colloidal dispersions, and microparticles.

Based on therapeutic application, the global self-injections market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.

On the basis of route of administration, the global self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.

On the basis of end-user, the global self-injections market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.

Based on geography the global self-injections market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Rest of the World

For More Details In-Depth Enquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-self-injections-market

TABLE OF CONTENTS:

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITY
3.4. CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL SELF-INJECTION MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
7. GLOBAL SELF-INJECTION MARKET, REIMBUSEMENT
7.1. OVERVIEW
7.2. REIMBURSEMENT SCENARIO
8. GLOBAL SELF-INJECTION MARKET, BY TYPE
8.1. OVERVIEW
8.2. GLOBAL SELF-INJECTION MARKET, BY PRODUCT TYPE
9. GLOBAL SELF-INJECTION MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. GLOBAL SELF-INJECTION MARKET, BY APPLICATION
9.3. HORMONAL DISORDERS
9.4. ONCOLOGY
9.5. AUTOIMMUNE DISEASES
9.6. ORPHAN DISEASE
9.7. OTHER APPLICATIONS
10. GLOBAL SELF-INJECTION MARKET, BY USAGE PATTERN
10.1. OVERVIEW
10.2. CURATIVE CARE
10.3. IMMUNIZATIONS
10.4. OTHER USAGE PATTERN
11. GLOBAL SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
11.1. OVERVIEW
11.2. SKIN
11.3. CIRCULATORY/ MUSKOSKELETAL
11.4. ORGANS
11.5. CENTRAL NERVOUS SYSTEM
12. GLOBAL SELF-INJECTION MARKET, BY END USER
12.1. OVERVIEW
12.2. HOSPITALS AND CLINICS
12.3. HOME HEALTHCARE SETTINGS
12.4. RESEARCH LABORATORIES
12.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
12.6. OTHER END USER
13. GLOBAL SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
13.1. OVERVIEW
13.1.1. HOSPITAL PHARMACY
13.1.2. PHARMACY STORES
13.1.3. DIRECT TENDER
13.1.4. ONLINE PHARMACY
14. GLOBAL SELF-INJECTION MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO
14.3. EUROPE
14.3.1. GERMANY
14.3.2. FRANCE
14.3.3. UK
14.3.4. SWITZERLAND
14.3.5. SPAIN
14.3.6. ITALY
14.3.7. NETHERLANDS
14.3.8. RUSSIA
14.3.9. TURKEY
14.3.10. BELGIUM
14.3.11. REST OF EUROPE
14.4. APAC
14.4.1. JAPAN
14.4.2. CHINA
14.4.3. SOUTH KOREA
14.4.4. INDIA
14.4.5. AUSTRALIA
14.4.6. SINGAPORE
14.4.7. THAILAND
14.4.8. MALAYSIA
14.4.9. INDONESIA
14.4.10. PHILIPPINES
14.4.11. REST OF APAC
14.5. SOUTH AMERICA
14.5.1. BRAZIL
14.5.2. REST OF SOUTH AMERICA
14.6. MEA
14.6.1. SOUTH AFRICA
14.6.2. REST OF MEA
15. GLOBAL SELF INJECTION MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: APAC
16. COMPANY PROFILES
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.3. SANOFI
16.4. SANDOZ INTERNATIONAL GMBH
16.6. UNILIFE CORPORATION
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.8. PFIZER INC.
16.9. IMPAX LABORATORIES, INC.
16.10. PENJET CORPORATION
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.13. ANTARES PHARMA
16.15. GERRESHEIMER AG
16.16. MYLAN N.V
16.17. NOVO NORDISK
16.18. OWEN MUMFORD LTD
16.19. PHARMAJET
16.20. SHL GROUP
16.21. YPSOMED
17. RELATED REPORTS

Related Report

Global Human Insulin Drugs and Delivery Devices Market – Industry Trends and Forecast to 2024

Global Human Insulin Drugs and Delivery Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-human-insulin-drugs-and-delivery-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.